Biodefense Industry on the Rise – Market Set to Hit $1.81 Billion Growth by 2030
Delray Beach, FL, July 30, 2025 (GLOBE NEWSWIRE) -- The report "Biodefense Market by Technology (GHz-band Wave, Microwave Heating, RF-EMR, Cold Plasma, Gamma, UV), Product (Decontamination (Sterilization Devices, Disinfection Units), Biosensors, AI Surveillance), Application, Region - Global Forecast to 2030", The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period.
The biodefense market is driven by increasing bioterrorism, growing geopolitical tensions, biological warfare risks, and advancements in technology. Biodefense encompasses a range of tools and systems designed to detect, prevent, and respond to biological threats, including infectious diseases, bioterrorism, and accidental pathogen releases. These include biosensors, rapid detection platforms, decontamination systems, mobile containment units, and AI-driven surveillance tools. The market for biodefense technology is experiencing strong growth due to increasing global concerns over pandemics, biological warfare, and emerging infectious diseases.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119088131
Major Key Players in the Biodefense Industry:
- STERIS (US),
- ASP International GmbH (a subsidiary of Fortive) (US),
- Ushio Inc. (Japan),
- Sotera Health Company (US), and
- Bioquell, An Ecolab Solution (UK).
Biodefense Market Segmentation:
Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period.
Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Hospitals are the initial point of contact for the identification of unusual infections or exposure to biological agents, and hence, they must have sophisticated containment systems, sterilization apparatus, and pathogen detection instruments in real time. With increasing bioterrorism, governments and health agencies are investing heavily in the upgrade of hospital biosafety facilities, such as Class III biological safety cabinets, mobile isolation units, and UV sterilization technology, all of which are becoming essential for modern biodefense infrastructure. These facilities need safe conditions to work with high-risk pathogens, which fuels the demand for low-temperature sterilizers, decontamination chambers, and air purification.
Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period.
Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period due to its significant contributions toward monitoring real-time pathogens, forecasting, and fast decision-making. AI facilitates the convergence and synthesis of large-scale environmental data and enables early threat detection and quick response coordination. Governments and health organizations globally are increasingly using AI platforms to track bio-threats across borders and to automatically report disease transmission for strategic purposes. Additionally, AI technologies are being integrated into biosensor networks, autonomous disinfecting robots, and predictive modeling applications utilized in hospitals, airports, and military bases.
Asia Pacific is projected to register the highest CAGR during the forecast period.
Asia Pacific is projected to register the highest CAGR in the biodefense market through the forecast period due to increasing investments in public health infrastructure, infectious disease surveillance, and military biosafety capacities. China, India, Japan, and Australia are comprehensively developing their biodefense capabilities. These countries are investing in mobile biosafety laboratories, near-real-time pathogen detection systems, and next-generation decontamination technologies to anticipate future biological threats. Also, the region is experiencing growth in biotechnology R&D, cross-border health security efforts, and government-backed biodefense programs.
Ask for Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=119088131
Recent Developments of Biodefense Market
- In February 2025, Thermo Fisher Scientific (US) announced the acquisition of the Solventum (US) Purification and Filtration business for USD 1.5 billion in cash.
- In September 2024, Synexis (US) announced a strategic partnership with Diversey (US), a global leader in hygiene and infection prevention solutions, to expand the reach of its Dry Hydrogen Peroxide (DHP™) technology.
- In June 2020, Ushio Inc. (Japan) announced a strategic alliance to supply Acuity Brands, Inc. (US) with its Care222 ultraviolet disinfection module, a far-UVC (222nm) technology that inactivates viruses and bacteria without harming human skin or eyes.
- In October 2022, ChargePoint Technology (US) collaborated with STERIS (US) to deliver integrated sterile transfer and containment solutions for pharmaceutical manufacturing.
- In May 2021, Synexis (US) and Trane Technology (US), a global climate solutions provider, expanded their agreement to integrate Synexis' Dry Hydrogen Peroxide (DHP™) technology into Trane's HVAC systems.
About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: www.marketsandmarkets.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
